Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters StreetEvents
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

TWi Pharmaceuticals Inc Receives First Trial Result of Lawsuit Filed by Takeda Pharmaceutical Co Ltd


Friday, 25 Oct 2013 03:30am EDT 

TWi Pharmaceuticals Inc (TWi Pharm) announced that it has received the first trial result of a lawsuit filed by Takeda Pharmaceutical Co Ltd against TWi Pharm with District Court of North California, according to which TWi Pharm's Dexilant generic drug infringed Takeda's United States patent (patent number: 7,737,282). TWi Pharm also announced that it will file an appeal against the result.